Group 2 Pulmonary hypertension due to left‐heart disease ‐ PDE5i vs placebo
All‐cause mortality · people with pulmonary hypertension due to left‐heart disease
Group 2 Pulmonary hypertension due to left‐heart disease ‐ PDE5i showed no clear difference in mortality compared with placebo (moderate certainty).
1 finding from 1 review
- OR 1.27 [0.28, 5.8]3 studies · 286 participantsModerate